Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD

INTRODUCTION: Soluble urokinase-type plasminogen activator receptor (suPAR) is upregulated by inflammation and plays a role in the pathogenesis of atherosclerosis. Chronic obstructive pulmonary disease (COPD) is associated with enhanced systemic inflammation and increased risk for atherosclerosis, h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Lung
Autores principales: Böcskei, Renáta M., Benczúr, Béla, Losonczy, György, Illyés, Miklós, Cziráki, Attila, Müller, Veronika, Bohács, Anikó, Bikov, András
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer US 2019
Materias:
COPD
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6486892/
https://ncbi.nlm.nih.gov/pubmed/30820636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00408-019-00211-w
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares